ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Bowen Huang
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2021: 4 papers · 2022: 1 paper
Papers 5
- Artificial intelligence in pancreatic cancer. Co-author DOI 10.7150/thno.77949↗
- Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2021/6682697↗
- Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. Co-author DOI 10.1155/2021/9949272↗
- Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.812785↗
- Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: a multi-center study. First author PMID 34249426↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junchao Guo · 3 shared papers, 2021–2022 · strength 0.40
- Paper Artificial intelligence in pancreatic cancer. DOI 10.7150/thno.77949↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. DOI 10.3389/fonc.2021.812785↗
- Chuanzhao Zhang · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Zhenchong Li · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Hongkai Zhuang · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Shanzhou Huang · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Zuyi Ma · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Yiping Zou · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Zixuan Zhou · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Baohua Hou · 3 shared papers, 2021 · strength 0.34
- Paper Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2021/6682697↗
- Paper Prognostic stratification based on a novel nomogram for left-sided pancreatic adenocarcinoma after surgical resection: … PMID 34249426↗
- Paper Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer. DOI 10.1155/2021/9949272↗
- Jianzhou Liu · 2 shared papers, 2021–2022 · strength 0.28
- Yuanfeng Gong · 2 shared papers, 2021 · strength 0.23
- Yizhi Wang · 1 shared paper, 2021 · strength 0.11
- Li Zhou · 1 shared paper, 2021 · strength 0.11
- Qi Zhou · 1 shared paper, 2021 · strength 0.11
- Jun Lü · 1 shared paper, 2021 · strength 0.11
- Yu Wang · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.